ALLERGY THERAPEUTICS PLC

Company number 05141592

Date	Type	Description	View / Download
06 Jan 2020	AA	Group of companies' accounts made up to 30 June 2019	(125 pages)
06 Jan 2020	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(2 pages)
20 Jun 2019	AP01	Appointment of Mrs Mary Geraldine Tavener as a director on 19 June 2019	(2 pages)
20 Jun 2019	CS01	Confirmation statement made on 1 June 2019 with no updates	(3 pages)
08 Jan 2019	AA	Group of companies' accounts made up to 30 June 2018	(112 pages)
21 Dec 2018	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(2 pages)
27 Nov 2018	MR01	Registration of charge 051415920002, created on 22 November 2018	(9 pages)
22 Nov 2018	CH01	Director's details changed for Dr Babatunde Adekunle Otulana on 22 November 2018	(2 pages)
08 Nov 2018	AP01	Appointment of Mr Scott Michael Leinenweber as a director on 7 November 2018	(2 pages)
08 Nov 2018	TM01	Termination of appointment of Jeffery Glen Barton as a director on 7 November 2018	(1 page)
21 Aug 2018	SH01	Statement of capital following an allotment of shares on 25 July 2018 GBP 646,016.949	(4 pages)
19 Jul 2018	SH01	Statement of capital following an allotment of shares on 30 May 2018 GBP 605,663.978	(3 pages)
12 Jul 2018	SH01	Statement of capital following an allotment of shares on 7 June 2018 GBP 605,663.978	(3 pages)
06 Jun 2018	CS01	Confirmation statement made on 1 June 2018 with updates	(4 pages)
29 Dec 2017	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(2 pages)
27 Dec 2017	AA	Group of companies' accounts made up to 30 June 2017	(119 pages)
21 Aug 2017	PSC02	Notification of Abbott Laboratories as a person with significant control on 24 July 2017	(1 page)
14 Aug 2017	TM01	Termination of appointment of Thomas Lander as a director on 30 June 2017	(1 page)
08 Jun 2017	SH01	Statement of capital following an allotment of shares on 13 April 2017 GBP 603,966.103	(3 pages)
07 Jun 2017	CS01	Confirmation statement made on 1 June 2017 with no updates	(3 pages)
07 Jun 2017	AP01	Appointment of Dr Babatunde Adekunle Otulana as a director on 6 June 2017	(2 pages)
09 Feb 2017	AP01	Appointment of Mr Jeffery Glen Barton as a director on 7 February 2017	(2 pages)
08 Feb 2017	TM01	Termination of appointment of Jean-Yves Frederic Georges Andre Pavee-Callu as a director on 7 February 2017	(1 page)
16 Dec 2016	AA	Group of companies' accounts made up to 30 June 2016	(80 pages)
15 Dec 2016	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(2 pages)